S SARS-CoV-2 Spike Glycoprotein mRNA

SARS-CoV-2 S protein (RBD, 319-541 aa) antibody (67758-1-Ig)

Recombinant SARS-CoV-2 Spike His Protein, CF 10549-CV-100: R&D Systems

Coronavirus (CoV) proteins, Introduction

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies, The Egyptian Journal of Internal Medicine

N SARS-CoV-2 Nucleocapsid mRNA

SARS-CoV-2 spike protein and messenger ribonucleic acid found to translocate into the nucleus

SARS-CoV-2 and the Nucleus

Emergence of the SARS-CoV-2 Omicron Variant: Current Treatments and Vaccines for COVID-19

タンパク質発現システム

IJMS, Free Full-Text

COVID-19, Infection Cycle

Frontiers The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens

mRNA Vaccines as an Efficient Approach for the Rapid and Robust Induction of Host Immunity Against SARS-CoV-2

Taksonomia, ekologia i zastosowania biotechnologiczne thraustochytrids: przegląd. – Ekologiczna Badan